logo
ResearchBunny Logo
A probiotic *Limosilactobacillus fermentum* GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome

Medicine and Health

A probiotic *Limosilactobacillus fermentum* GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome

T. Zhou, J. Wu, et al.

This groundbreaking study reveals the potential of the probiotic Limosilactobacillus fermentum GR-3 in combating colitis-associated tumorigenesis in mice. With a notable 51.2% reduction in tumor incidence, this research showcases the powerful health benefits of gut microbiome modulation, led by an expert team from Lanzhou University and Augusta University.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny